Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel

Long Term Adherence and Efficacy of Etanercept in SpA Iraqi Patients: 7 Year Data From Local Registry

This study is to evaluate local data in Iraqi patients with Spondyloarthropathies on Enbrel treatment with regards to efficacy and adherence using data from the Baghdad Teaching Hospital (Rheumatology Center)

Inclusion Criteria:

• Diagnosed SpA patients
• 18 years of age and older.
• Did not receive previous other biological treatments.
• Patients have at least 1 year on Enbrel.

Exclusion Criteria:

• Had previously used another biological treatments.
• Use of etanercept for less than 1 year duration.